Reference formulation
Sponsors
GlaxoSmithKline, Severance Hospital, Galeno Desenvolvimento de Pesquisas Clínicas, Pfizer
Conditions
ContraceptionDepressive DisorderHealthyHypogonadismProstatic Hyperplasia
Phase 1
SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin
CompletedNCT01262989
Start: 2010-01-04End: 2010-01-26Updated: 2017-08-14
Paxil CR Bioequivalence Study Brazil
CompletedNCT01316926
Start: 2009-09-09End: 2009-10-05Updated: 2018-06-20
SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin
CompletedNCT01330303
Start: 2009-12-08End: 2009-12-22Updated: 2017-08-01
Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male Volunteers
CompletedNCT01823913
Start: 2012-07-31End: 2012-09-30Updated: 2013-04-11
Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers
CompletedNCT01823900
Start: 2012-01-31End: 2012-03-31Updated: 2013-04-11
Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate
CompletedNCT03443089
Start: 2017-03-31End: 2017-08-01Updated: 2018-02-23
A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males
CompletedNCT03792477
Start: 2019-01-19End: 2020-04-02Updated: 2021-04-29